Avingtrans Regulatory News (AVG)

27 January 2026

Avingtrans Plc

("Avingtrans", the "Company", or the "Group")

Exercise of Options & TVR

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that on 27 January 2026, the Company was notified of the exercise of 138,900 CSOP options over ordinary shares of 5p each in the Company ("Ordinary Shares") by certain non-PDMR employees pursuant to the Company's CSOP.

Issue of Equity

Application has been made for the admission to trading on AIM for the 138,900 new Ordinary Shares ("Admission"). It is expected that Admission will become effective on 4 February 2026.

Total Voting Rights

Following the issue of the 138,900 new Ordinary Shares, the Company will have a total of 33,269,322 Ordinary Shares in issue. The Company does not hold any shares in Treasury. 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules

Enquiries: